Is UNII-3T1SS4E7AG Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-3T1SS4E7AG? Is UNII-3T1SS4E7AG safe for nursing mother and child? Does UNII-3T1SS4E7AG extracts into breast milk? Does UNII-3T1SS4E7AG has any long term or short term side effects on infants? Can UNII-3T1SS4E7AG influence milk supply or can UNII-3T1SS4E7AG decrease milk supply in lactating mothers?
Answer by DrLact: About UNII-3T1SS4E7AG usage in lactation
No information is available on the clinical use of UNII-3T1SS4E7AG during breastfeeding. Because UNII-3T1SS4E7AG is 98.5% bound to plasma proteins and its active metabolite is 96.6% bound to plasma proteins, the amount in milk is likely to be low. However, the half-life of UNII-3T1SS4E7AG is 137 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during UNII-3T1SS4E7AG therapy and for at least 1 month after the end of therapy.
Alternate Drugs
Cisplatin(Unsafe)
Busulfan(Dangerous)
Imatinib(Unsafe)
Azelaic Acid(Safe)
Letrozole(Dangerous)
Ipilimumab(Unsafe)
Exemestane(Dangerous)
Cetuximab(Unsafe)
Docetaxel(Dangerous)
Nivolumab(Unsafe)
Carboplatin(Dangerous)
Vinblastine(Dangerous)
Pazopanib(Unsafe)
Paclitaxel(Dangerous)
Gemcitabine(Dangerous)
Bleomycin(Dangerous)
Vincristine(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Tamoxifen(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Mitoxantrone(Dangerous)
Rituximab(Low Risk)
Mercaptopurine(Safe)
Cladribine(Dangerous)
Dactinomycin(Dangerous)
Bevacizumab(Low Risk)
Hydroxyurea(Low Risk)
Thioguanine(Dangerous)
Etoposide(Dangerous)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Doxorubicin(Dangerous)
Cyclophosphamide(Dangerous)
Nilotinib(Unsafe)
Trastuzumab(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Gemcitabine(Dangerous)
Allopurinol(Safe)
Orlistat(Low Risk)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)